Anzeige
Mehr »
Login
Donnerstag, 25.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Wie die Revolution der sauberen Energie eine solide Investitionsmöglichkeit bieten könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von RTTNews

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
MiVertiv Holdings Co Q1 Earnings Summary
MiUnited Micro Electronics Corp. Q1 Profit Drops
MiGroup 1 Automotive, Inc Q1 Profit Decreases, but beats estimates
MiLithia Motors Inc Q1 Profit Decreases, misses estimates
MiASSA ABLOY Q1 Net Income Rises
MiSound Energy Slips To Loss In FY23; Concerned About Continuing As Going Concern; Stock Dips
MiTracsis Posts Pretax Loss Of In H1
MiBreedon Q1 Revenues Down On Softer Volumes
MiQuilter Reports Q1 Average AuMA Of £108.3 Bln
MiKONE Oyj Q1 Earnings Climb; Sees Full-year Sales Growth Of Up To 5% - Update
MiSEB Q1 Profit Edges Up
MiVolvo Cars Q1 Profit Down, Core Operating Profit Up; Sees Growth In FY24 Profit, Demand
MiKPN Q1 Net Profit Declines; Raises 2024 Outlook
MiHandelsbanken Q1 Profit Down, Despite Higher Net Interest Income; Plans Strategic Refocus
MiIpsen Q1 Total-sales Up 13.3% At CER; Confirms 2024 Financial Guidance
MiCentessa Pharma Prices Public Offering Of About 10.81 Mln ADSs At $9.25/ADS
MiHighwoods Properties Q1 FFO Down; Updates 2024 FFO/shr Outlook
MiEastGroup Properties Inc. Bottom Line Advances In Q1
MiVicor Corp Q1 Profit Declines, misses estimates
MiManhattan Associates Q1 Profit Increases, beats estimates
DiCanadian National Railway Co Profit Retreats In Q1, misses estimates
DiBeiGene's Tislelizumab Granted EC Approval For Non-Small Cell Lung Cancer Treatment
DiSandvik To Acquire Majority Stake In Suzhou Ahno
DiTheriva Biologics Announces Positive Data From Phase 1 Trial Of VCN-01 In Intraocular Retinoblastoma
DiCommunity Bank System Q1 Profit Surges; Sees Continued Revenue Growth Ahead